nodes	percent_of_prediction	percent_of_DWPC	metapath
Almotriptan—migraine—Prednisone—chronic obstructive pulmonary disease	0.366	1	CpDpCtD
Almotriptan—CYP1A2—chronic obstructive pulmonary disease	0.229	1	CbGaD
Almotriptan—CYP2E1—Aminophylline—chronic obstructive pulmonary disease	0.0341	0.137	CbGbCtD
Almotriptan—CYP2C19—Formoterol—chronic obstructive pulmonary disease	0.0251	0.101	CbGbCtD
Almotriptan—CYP2C19—Arformoterol—chronic obstructive pulmonary disease	0.0251	0.101	CbGbCtD
Almotriptan—CYP2C8—Montelukast—chronic obstructive pulmonary disease	0.0227	0.091	CbGbCtD
Almotriptan—CYP1A2—Aminophylline—chronic obstructive pulmonary disease	0.0197	0.079	CbGbCtD
Almotriptan—CYP2D6—Arformoterol—chronic obstructive pulmonary disease	0.0191	0.0766	CbGbCtD
Almotriptan—CYP2D6—Formoterol—chronic obstructive pulmonary disease	0.0191	0.0766	CbGbCtD
Almotriptan—CYP2D6—Tiotropium—chronic obstructive pulmonary disease	0.017	0.0683	CbGbCtD
Almotriptan—CYP3A4—Salbutamol—chronic obstructive pulmonary disease	0.016	0.0643	CbGbCtD
Almotriptan—FMO3—sweat—chronic obstructive pulmonary disease	0.0155	0.664	CbGeAlD
Almotriptan—CYP3A4—Tiotropium—chronic obstructive pulmonary disease	0.0108	0.0434	CbGbCtD
Almotriptan—CYP2C19—Prednisone—chronic obstructive pulmonary disease	0.0106	0.0423	CbGbCtD
Almotriptan—CYP3A4—Aminophylline—chronic obstructive pulmonary disease	0.0103	0.0414	CbGbCtD
Almotriptan—CYP3A4—Montelukast—chronic obstructive pulmonary disease	0.00921	0.0369	CbGbCtD
Almotriptan—CYP3A4—Prednisolone—chronic obstructive pulmonary disease	0.0054	0.0217	CbGbCtD
Almotriptan—CYP3A4—Prednisone—chronic obstructive pulmonary disease	0.0051	0.0205	CbGbCtD
Almotriptan—FMO3—respiratory system—chronic obstructive pulmonary disease	0.00139	0.0597	CbGeAlD
Almotriptan—FMO3—bronchus—chronic obstructive pulmonary disease	0.00115	0.0491	CbGeAlD
Almotriptan—FMO3—lung—chronic obstructive pulmonary disease	0.000739	0.0317	CbGeAlD
Almotriptan—HTR1D—connective tissue—chronic obstructive pulmonary disease	0.000696	0.0298	CbGeAlD
Almotriptan—Rizatriptan—CYP1A2—chronic obstructive pulmonary disease	0.000611	0.272	CrCbGaD
Almotriptan—MAOA—respiratory system—chronic obstructive pulmonary disease	0.000602	0.0258	CbGeAlD
Almotriptan—Zolmitriptan—CYP1A2—chronic obstructive pulmonary disease	0.000559	0.249	CrCbGaD
Almotriptan—MAOA—connective tissue—chronic obstructive pulmonary disease	0.00053	0.0227	CbGeAlD
Almotriptan—CYP1A2—respiratory system—chronic obstructive pulmonary disease	0.000503	0.0215	CbGeAlD
Almotriptan—MAOA—bronchus—chronic obstructive pulmonary disease	0.000496	0.0213	CbGeAlD
Almotriptan—Melatonin—MPO—chronic obstructive pulmonary disease	0.000494	0.22	CrCbGaD
Almotriptan—CYP2E1—respiratory system—chronic obstructive pulmonary disease	0.000452	0.0194	CbGeAlD
Almotriptan—MAOA—trachea—chronic obstructive pulmonary disease	0.000445	0.0191	CbGeAlD
Almotriptan—MAOA—lung—chronic obstructive pulmonary disease	0.00032	0.0137	CbGeAlD
Almotriptan—Melatonin—CYP1A1—chronic obstructive pulmonary disease	0.000297	0.132	CrCbGaD
Almotriptan—Melatonin—CYP1A2—chronic obstructive pulmonary disease	0.000286	0.127	CrCbGaD
Almotriptan—CYP1A2—lung—chronic obstructive pulmonary disease	0.000267	0.0114	CbGeAlD
Almotriptan—CYP2E1—lung—chronic obstructive pulmonary disease	0.00024	0.0103	CbGeAlD
Almotriptan—Palpitations—Arformoterol—chronic obstructive pulmonary disease	0.000169	0.00185	CcSEcCtD
Almotriptan—Gastrointestinal pain—Aminophylline—chronic obstructive pulmonary disease	0.000168	0.00184	CcSEcCtD
Almotriptan—Ill-defined disorder—Salbutamol—chronic obstructive pulmonary disease	0.000167	0.00184	CcSEcCtD
Almotriptan—Gastrointestinal disorder—Tiotropium—chronic obstructive pulmonary disease	0.000167	0.00183	CcSEcCtD
Almotriptan—Agitation—Salbutamol—chronic obstructive pulmonary disease	0.000166	0.00182	CcSEcCtD
Almotriptan—Palpitations—Montelukast—chronic obstructive pulmonary disease	0.000165	0.00181	CcSEcCtD
Almotriptan—Hypertension—Arformoterol—chronic obstructive pulmonary disease	0.000165	0.00181	CcSEcCtD
Almotriptan—Hypertension—Formoterol—chronic obstructive pulmonary disease	0.000165	0.00181	CcSEcCtD
Almotriptan—Angioedema—Salbutamol—chronic obstructive pulmonary disease	0.000165	0.00181	CcSEcCtD
Almotriptan—Malaise—Salbutamol—chronic obstructive pulmonary disease	0.000163	0.00178	CcSEcCtD
Almotriptan—Chest pain—Arformoterol—chronic obstructive pulmonary disease	0.000163	0.00178	CcSEcCtD
Almotriptan—Arthralgia—Formoterol—chronic obstructive pulmonary disease	0.000163	0.00178	CcSEcCtD
Almotriptan—Myalgia—Arformoterol—chronic obstructive pulmonary disease	0.000163	0.00178	CcSEcCtD
Almotriptan—Arthralgia—Arformoterol—chronic obstructive pulmonary disease	0.000163	0.00178	CcSEcCtD
Almotriptan—Chest pain—Formoterol—chronic obstructive pulmonary disease	0.000163	0.00178	CcSEcCtD
Almotriptan—Myalgia—Formoterol—chronic obstructive pulmonary disease	0.000163	0.00178	CcSEcCtD
Almotriptan—Convulsion—Montelukast—chronic obstructive pulmonary disease	0.000162	0.00178	CcSEcCtD
Almotriptan—Anxiety—Arformoterol—chronic obstructive pulmonary disease	0.000162	0.00178	CcSEcCtD
Almotriptan—Anxiety—Formoterol—chronic obstructive pulmonary disease	0.000162	0.00178	CcSEcCtD
Almotriptan—Vertigo—Salbutamol—chronic obstructive pulmonary disease	0.000162	0.00178	CcSEcCtD
Almotriptan—Abdominal pain—Aminophylline—chronic obstructive pulmonary disease	0.000162	0.00178	CcSEcCtD
Almotriptan—Body temperature increased—Aminophylline—chronic obstructive pulmonary disease	0.000162	0.00178	CcSEcCtD
Almotriptan—Syncope—Salbutamol—chronic obstructive pulmonary disease	0.000162	0.00178	CcSEcCtD
Almotriptan—Unspecified disorder of skin and subcutaneous tissue—Arformoterol—chronic obstructive pulmonary disease	0.000162	0.00177	CcSEcCtD
Almotriptan—Unspecified disorder of skin and subcutaneous tissue—Formoterol—chronic obstructive pulmonary disease	0.000162	0.00177	CcSEcCtD
Almotriptan—Neuropathy—Prednisone—chronic obstructive pulmonary disease	0.000161	0.00177	CcSEcCtD
Almotriptan—Discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000161	0.00176	CcSEcCtD
Almotriptan—Discomfort—Formoterol—chronic obstructive pulmonary disease	0.000161	0.00176	CcSEcCtD
Almotriptan—Palpitations—Salbutamol—chronic obstructive pulmonary disease	0.000159	0.00175	CcSEcCtD
Almotriptan—Myalgia—Montelukast—chronic obstructive pulmonary disease	0.000159	0.00175	CcSEcCtD
Almotriptan—Arthralgia—Montelukast—chronic obstructive pulmonary disease	0.000159	0.00175	CcSEcCtD
Almotriptan—Dry mouth—Arformoterol—chronic obstructive pulmonary disease	0.000159	0.00175	CcSEcCtD
Almotriptan—Dry mouth—Formoterol—chronic obstructive pulmonary disease	0.000159	0.00175	CcSEcCtD
Almotriptan—Anxiety—Montelukast—chronic obstructive pulmonary disease	0.000159	0.00174	CcSEcCtD
Almotriptan—Loss of consciousness—Salbutamol—chronic obstructive pulmonary disease	0.000159	0.00174	CcSEcCtD
Almotriptan—Unspecified disorder of skin and subcutaneous tissue—Montelukast—chronic obstructive pulmonary disease	0.000158	0.00174	CcSEcCtD
Almotriptan—Gastrointestinal pain—Tiotropium—chronic obstructive pulmonary disease	0.000158	0.00173	CcSEcCtD
Almotriptan—Anaphylactic shock—Formoterol—chronic obstructive pulmonary disease	0.000156	0.00171	CcSEcCtD
Almotriptan—Anaphylactic shock—Arformoterol—chronic obstructive pulmonary disease	0.000156	0.00171	CcSEcCtD
Almotriptan—Hypertension—Salbutamol—chronic obstructive pulmonary disease	0.000156	0.00171	CcSEcCtD
Almotriptan—Chest pain—Salbutamol—chronic obstructive pulmonary disease	0.000154	0.00169	CcSEcCtD
Almotriptan—Arthralgia—Salbutamol—chronic obstructive pulmonary disease	0.000154	0.00169	CcSEcCtD
Almotriptan—Myalgia—Salbutamol—chronic obstructive pulmonary disease	0.000154	0.00169	CcSEcCtD
Almotriptan—Anxiety—Salbutamol—chronic obstructive pulmonary disease	0.000153	0.00168	CcSEcCtD
Almotriptan—Nervous system disorder—Formoterol—chronic obstructive pulmonary disease	0.000153	0.00168	CcSEcCtD
Almotriptan—Nervous system disorder—Arformoterol—chronic obstructive pulmonary disease	0.000153	0.00168	CcSEcCtD
Almotriptan—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.000153	0.00168	CcSEcCtD
Almotriptan—Anaphylactic shock—Montelukast—chronic obstructive pulmonary disease	0.000153	0.00168	CcSEcCtD
Almotriptan—Tachycardia—Arformoterol—chronic obstructive pulmonary disease	0.000152	0.00167	CcSEcCtD
Almotriptan—Tachycardia—Formoterol—chronic obstructive pulmonary disease	0.000152	0.00167	CcSEcCtD
Almotriptan—Discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000152	0.00166	CcSEcCtD
Almotriptan—Muscular weakness—Prednisolone—chronic obstructive pulmonary disease	0.000152	0.00166	CcSEcCtD
Almotriptan—Skin disorder—Arformoterol—chronic obstructive pulmonary disease	0.000151	0.00166	CcSEcCtD
Almotriptan—Skin disorder—Formoterol—chronic obstructive pulmonary disease	0.000151	0.00166	CcSEcCtD
Almotriptan—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.000151	0.00166	CcSEcCtD
Almotriptan—Dry mouth—Salbutamol—chronic obstructive pulmonary disease	0.00015	0.00165	CcSEcCtD
Almotriptan—Nervous system disorder—Montelukast—chronic obstructive pulmonary disease	0.00015	0.00164	CcSEcCtD
Almotriptan—Skin disorder—Montelukast—chronic obstructive pulmonary disease	0.000148	0.00163	CcSEcCtD
Almotriptan—Euphoric mood—Prednisone—chronic obstructive pulmonary disease	0.000148	0.00162	CcSEcCtD
Almotriptan—Anaphylactic shock—Salbutamol—chronic obstructive pulmonary disease	0.000147	0.00162	CcSEcCtD
Almotriptan—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.000145	0.00159	CcSEcCtD
Almotriptan—Shock—Salbutamol—chronic obstructive pulmonary disease	0.000145	0.00159	CcSEcCtD
Almotriptan—Sweating increased—Prednisolone—chronic obstructive pulmonary disease	0.000145	0.00159	CcSEcCtD
Almotriptan—Nervous system disorder—Salbutamol—chronic obstructive pulmonary disease	0.000144	0.00158	CcSEcCtD
Almotriptan—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	0.000144	0.00158	CcSEcCtD
Almotriptan—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	0.000143	0.00157	CcSEcCtD
Almotriptan—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.000142	0.00156	CcSEcCtD
Almotriptan—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	0.000142	0.00156	CcSEcCtD
Almotriptan—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.000142	0.00156	CcSEcCtD
Almotriptan—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000142	0.00156	CcSEcCtD
Almotriptan—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.000141	0.00155	CcSEcCtD
Almotriptan—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.000141	0.00155	CcSEcCtD
Almotriptan—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.00014	0.00154	CcSEcCtD
Almotriptan—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.000139	0.00153	CcSEcCtD
Almotriptan—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.000139	0.00153	CcSEcCtD
Almotriptan—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.000139	0.00153	CcSEcCtD
Almotriptan—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.000139	0.00152	CcSEcCtD
Almotriptan—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.000139	0.00152	CcSEcCtD
Almotriptan—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.000138	0.00152	CcSEcCtD
Almotriptan—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.000137	0.00151	CcSEcCtD
Almotriptan—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.000137	0.00151	CcSEcCtD
Almotriptan—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.000137	0.0015	CcSEcCtD
Almotriptan—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.000137	0.0015	CcSEcCtD
Almotriptan—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.000136	0.00149	CcSEcCtD
Almotriptan—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000135	0.00149	CcSEcCtD
Almotriptan—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.000135	0.00148	CcSEcCtD
Almotriptan—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.000135	0.00148	CcSEcCtD
Almotriptan—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.000134	0.00148	CcSEcCtD
Almotriptan—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.000134	0.00148	CcSEcCtD
Almotriptan—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.000134	0.00148	CcSEcCtD
Almotriptan—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000134	0.00147	CcSEcCtD
Almotriptan—Pain—Formoterol—chronic obstructive pulmonary disease	0.000133	0.00146	CcSEcCtD
Almotriptan—Pain—Arformoterol—chronic obstructive pulmonary disease	0.000133	0.00146	CcSEcCtD
Almotriptan—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.000133	0.00146	CcSEcCtD
Almotriptan—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.000132	0.00145	CcSEcCtD
Almotriptan—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.000132	0.00145	CcSEcCtD
Almotriptan—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.000132	0.00144	CcSEcCtD
Almotriptan—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.000131	0.00144	CcSEcCtD
Almotriptan—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.000131	0.00144	CcSEcCtD
Almotriptan—Pain—Montelukast—chronic obstructive pulmonary disease	0.000131	0.00143	CcSEcCtD
Almotriptan—Acute coronary syndrome—Prednisolone—chronic obstructive pulmonary disease	0.000131	0.00143	CcSEcCtD
Almotriptan—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.00013	0.00143	CcSEcCtD
Almotriptan—Myocardial infarction—Prednisolone—chronic obstructive pulmonary disease	0.00013	0.00142	CcSEcCtD
Almotriptan—Neuropathy peripheral—Prednisolone—chronic obstructive pulmonary disease	0.00013	0.00142	CcSEcCtD
Almotriptan—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.00013	0.00142	CcSEcCtD
Almotriptan—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000129	0.00142	CcSEcCtD
Almotriptan—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000129	0.00142	CcSEcCtD
Almotriptan—Conjunctivitis—Prednisolone—chronic obstructive pulmonary disease	0.000129	0.00141	CcSEcCtD
Almotriptan—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.000128	0.00141	CcSEcCtD
Almotriptan—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.000128	0.00141	CcSEcCtD
Almotriptan—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000128	0.00141	CcSEcCtD
Almotriptan—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000128	0.0014	CcSEcCtD
Almotriptan—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.000127	0.0014	CcSEcCtD
Almotriptan—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.000127	0.0014	CcSEcCtD
Almotriptan—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.000127	0.00139	CcSEcCtD
Almotriptan—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.000127	0.00139	CcSEcCtD
Almotriptan—Pain—Salbutamol—chronic obstructive pulmonary disease	0.000126	0.00138	CcSEcCtD
Almotriptan—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.000125	0.00137	CcSEcCtD
Almotriptan—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.000123	0.00135	CcSEcCtD
Almotriptan—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.000123	0.00135	CcSEcCtD
Almotriptan—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.000123	0.00135	CcSEcCtD
Almotriptan—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.000123	0.00135	CcSEcCtD
Almotriptan—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000123	0.00135	CcSEcCtD
Almotriptan—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000122	0.00134	CcSEcCtD
Almotriptan—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000122	0.00134	CcSEcCtD
Almotriptan—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000122	0.00134	CcSEcCtD
Almotriptan—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.000121	0.00133	CcSEcCtD
Almotriptan—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000121	0.00133	CcSEcCtD
Almotriptan—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.000121	0.00132	CcSEcCtD
Almotriptan—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.000121	0.00132	CcSEcCtD
Almotriptan—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.00012	0.00132	CcSEcCtD
Almotriptan—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.000116	0.00128	CcSEcCtD
Almotriptan—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.000116	0.00128	CcSEcCtD
Almotriptan—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.000115	0.00126	CcSEcCtD
Almotriptan—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.000115	0.00126	CcSEcCtD
Almotriptan—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000115	0.00126	CcSEcCtD
Almotriptan—Visual impairment—Prednisolone—chronic obstructive pulmonary disease	0.000115	0.00126	CcSEcCtD
Almotriptan—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.000113	0.00123	CcSEcCtD
Almotriptan—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.000112	0.00123	CcSEcCtD
Almotriptan—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.000112	0.00123	CcSEcCtD
Almotriptan—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.00011	0.00121	CcSEcCtD
Almotriptan—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.00011	0.00121	CcSEcCtD
Almotriptan—Muscular weakness—Prednisone—chronic obstructive pulmonary disease	0.00011	0.00121	CcSEcCtD
Almotriptan—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.00011	0.0012	CcSEcCtD
Almotriptan—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.000108	0.00119	CcSEcCtD
Almotriptan—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.000108	0.00119	CcSEcCtD
Almotriptan—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000107	0.00117	CcSEcCtD
Almotriptan—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000107	0.00117	CcSEcCtD
Almotriptan—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.000106	0.00116	CcSEcCtD
Almotriptan—Sweating increased—Prednisone—chronic obstructive pulmonary disease	0.000105	0.00115	CcSEcCtD
Almotriptan—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000104	0.00115	CcSEcCtD
Almotriptan—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.000104	0.00114	CcSEcCtD
Almotriptan—Erythema—Prednisolone—chronic obstructive pulmonary disease	0.000103	0.00114	CcSEcCtD
Almotriptan—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000103	0.00113	CcSEcCtD
Almotriptan—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000103	0.00113	CcSEcCtD
Almotriptan—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000101	0.00111	CcSEcCtD
Almotriptan—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.000101	0.00111	CcSEcCtD
Almotriptan—Vomiting—Formoterol—chronic obstructive pulmonary disease	9.91e-05	0.00109	CcSEcCtD
Almotriptan—Vomiting—Arformoterol—chronic obstructive pulmonary disease	9.91e-05	0.00109	CcSEcCtD
Almotriptan—Rash—Formoterol—chronic obstructive pulmonary disease	9.83e-05	0.00108	CcSEcCtD
Almotriptan—Rash—Arformoterol—chronic obstructive pulmonary disease	9.83e-05	0.00108	CcSEcCtD
Almotriptan—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	9.82e-05	0.00108	CcSEcCtD
Almotriptan—Dermatitis—Formoterol—chronic obstructive pulmonary disease	9.82e-05	0.00108	CcSEcCtD
Almotriptan—Headache—Arformoterol—chronic obstructive pulmonary disease	9.77e-05	0.00107	CcSEcCtD
Almotriptan—Headache—Formoterol—chronic obstructive pulmonary disease	9.77e-05	0.00107	CcSEcCtD
Almotriptan—Vision blurred—Prednisolone—chronic obstructive pulmonary disease	9.75e-05	0.00107	CcSEcCtD
Almotriptan—Dizziness—Salbutamol—chronic obstructive pulmonary disease	9.74e-05	0.00107	CcSEcCtD
Almotriptan—Hyperglycaemia—Prednisone—chronic obstructive pulmonary disease	9.73e-05	0.00107	CcSEcCtD
Almotriptan—Vomiting—Montelukast—chronic obstructive pulmonary disease	9.71e-05	0.00107	CcSEcCtD
Almotriptan—Rash—Montelukast—chronic obstructive pulmonary disease	9.63e-05	0.00106	CcSEcCtD
Almotriptan—Dermatitis—Montelukast—chronic obstructive pulmonary disease	9.62e-05	0.00106	CcSEcCtD
Almotriptan—Ill-defined disorder—Prednisolone—chronic obstructive pulmonary disease	9.6e-05	0.00105	CcSEcCtD
Almotriptan—Headache—Montelukast—chronic obstructive pulmonary disease	9.57e-05	0.00105	CcSEcCtD
Almotriptan—Acute coronary syndrome—Prednisone—chronic obstructive pulmonary disease	9.48e-05	0.00104	CcSEcCtD
Almotriptan—Angioedema—Prednisolone—chronic obstructive pulmonary disease	9.45e-05	0.00104	CcSEcCtD
Almotriptan—Myocardial infarction—Prednisone—chronic obstructive pulmonary disease	9.43e-05	0.00103	CcSEcCtD
Almotriptan—Neuropathy peripheral—Prednisone—chronic obstructive pulmonary disease	9.43e-05	0.00103	CcSEcCtD
Almotriptan—Vomiting—Salbutamol—chronic obstructive pulmonary disease	9.36e-05	0.00103	CcSEcCtD
Almotriptan—Malaise—Prednisolone—chronic obstructive pulmonary disease	9.33e-05	0.00102	CcSEcCtD
Almotriptan—Vertigo—Prednisolone—chronic obstructive pulmonary disease	9.3e-05	0.00102	CcSEcCtD
Almotriptan—Rash—Salbutamol—chronic obstructive pulmonary disease	9.28e-05	0.00102	CcSEcCtD
Almotriptan—Syncope—Prednisolone—chronic obstructive pulmonary disease	9.28e-05	0.00102	CcSEcCtD
Almotriptan—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	9.27e-05	0.00102	CcSEcCtD
Almotriptan—Nausea—Arformoterol—chronic obstructive pulmonary disease	9.26e-05	0.00102	CcSEcCtD
Almotriptan—Nausea—Formoterol—chronic obstructive pulmonary disease	9.26e-05	0.00102	CcSEcCtD
Almotriptan—Headache—Salbutamol—chronic obstructive pulmonary disease	9.22e-05	0.00101	CcSEcCtD
Almotriptan—Loss of consciousness—Prednisolone—chronic obstructive pulmonary disease	9.09e-05	0.000998	CcSEcCtD
Almotriptan—Nausea—Montelukast—chronic obstructive pulmonary disease	9.07e-05	0.000995	CcSEcCtD
Almotriptan—Convulsion—Prednisolone—chronic obstructive pulmonary disease	8.96e-05	0.000984	CcSEcCtD
Almotriptan—Hypertension—Prednisolone—chronic obstructive pulmonary disease	8.93e-05	0.00098	CcSEcCtD
Almotriptan—Nausea—Salbutamol—chronic obstructive pulmonary disease	8.74e-05	0.00096	CcSEcCtD
Almotriptan—Discomfort—Prednisolone—chronic obstructive pulmonary disease	8.7e-05	0.000955	CcSEcCtD
Almotriptan—Anaphylactic shock—Prednisolone—chronic obstructive pulmonary disease	8.44e-05	0.000927	CcSEcCtD
Almotriptan—Shock—Prednisolone—chronic obstructive pulmonary disease	8.31e-05	0.000912	CcSEcCtD
Almotriptan—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	8.24e-05	0.000904	CcSEcCtD
Almotriptan—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	8.16e-05	0.000896	CcSEcCtD
Almotriptan—Eye disorder—Prednisone—chronic obstructive pulmonary disease	8.07e-05	0.000886	CcSEcCtD
Almotriptan—Immune system disorder—Prednisone—chronic obstructive pulmonary disease	7.8e-05	0.000856	CcSEcCtD
Almotriptan—Insomnia—Prednisolone—chronic obstructive pulmonary disease	7.64e-05	0.000838	CcSEcCtD
Almotriptan—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	7.58e-05	0.000832	CcSEcCtD
Almotriptan—Mental disorder—Prednisone—chronic obstructive pulmonary disease	7.57e-05	0.00083	CcSEcCtD
Almotriptan—Erythema—Prednisone—chronic obstructive pulmonary disease	7.52e-05	0.000825	CcSEcCtD
Almotriptan—Pain—Prednisolone—chronic obstructive pulmonary disease	7.22e-05	0.000792	CcSEcCtD
Almotriptan—Vision blurred—Prednisone—chronic obstructive pulmonary disease	7.09e-05	0.000777	CcSEcCtD
Almotriptan—Ill-defined disorder—Prednisone—chronic obstructive pulmonary disease	6.98e-05	0.000765	CcSEcCtD
Almotriptan—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	6.96e-05	0.000764	CcSEcCtD
Almotriptan—Agitation—Prednisone—chronic obstructive pulmonary disease	6.91e-05	0.000758	CcSEcCtD
Almotriptan—Angioedema—Prednisone—chronic obstructive pulmonary disease	6.87e-05	0.000754	CcSEcCtD
Almotriptan—Malaise—Prednisone—chronic obstructive pulmonary disease	6.78e-05	0.000744	CcSEcCtD
Almotriptan—Vertigo—Prednisone—chronic obstructive pulmonary disease	6.75e-05	0.000741	CcSEcCtD
Almotriptan—Syncope—Prednisone—chronic obstructive pulmonary disease	6.74e-05	0.00074	CcSEcCtD
Almotriptan—Loss of consciousness—Prednisone—chronic obstructive pulmonary disease	6.61e-05	0.000725	CcSEcCtD
Almotriptan—Convulsion—Prednisone—chronic obstructive pulmonary disease	6.51e-05	0.000715	CcSEcCtD
Almotriptan—Hypertension—Prednisone—chronic obstructive pulmonary disease	6.49e-05	0.000712	CcSEcCtD
Almotriptan—Arthralgia—Prednisone—chronic obstructive pulmonary disease	6.4e-05	0.000702	CcSEcCtD
Almotriptan—Myalgia—Prednisone—chronic obstructive pulmonary disease	6.4e-05	0.000702	CcSEcCtD
Almotriptan—Anxiety—Prednisone—chronic obstructive pulmonary disease	6.38e-05	0.0007	CcSEcCtD
Almotriptan—Unspecified disorder of skin and subcutaneous tissue—Prednisone—chronic obstructive pulmonary disease	6.36e-05	0.000698	CcSEcCtD
Almotriptan—Discomfort—Prednisone—chronic obstructive pulmonary disease	6.32e-05	0.000694	CcSEcCtD
Almotriptan—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	6.22e-05	0.000683	CcSEcCtD
Almotriptan—Anaphylactic shock—Prednisone—chronic obstructive pulmonary disease	6.14e-05	0.000673	CcSEcCtD
Almotriptan—Shock—Prednisone—chronic obstructive pulmonary disease	6.04e-05	0.000662	CcSEcCtD
Almotriptan—Nervous system disorder—Prednisone—chronic obstructive pulmonary disease	6.02e-05	0.00066	CcSEcCtD
Almotriptan—Tachycardia—Prednisone—chronic obstructive pulmonary disease	5.99e-05	0.000657	CcSEcCtD
Almotriptan—Skin disorder—Prednisone—chronic obstructive pulmonary disease	5.96e-05	0.000654	CcSEcCtD
Almotriptan—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	5.93e-05	0.000651	CcSEcCtD
Almotriptan—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	5.59e-05	0.000613	CcSEcCtD
Almotriptan—Dizziness—Prednisolone—chronic obstructive pulmonary disease	5.58e-05	0.000613	CcSEcCtD
Almotriptan—Insomnia—Prednisone—chronic obstructive pulmonary disease	5.55e-05	0.000609	CcSEcCtD
Almotriptan—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	5.51e-05	0.000605	CcSEcCtD
Almotriptan—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	5.4e-05	0.000593	CcSEcCtD
Almotriptan—Rash—Prednisolone—chronic obstructive pulmonary disease	5.32e-05	0.000584	CcSEcCtD
Almotriptan—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	5.32e-05	0.000584	CcSEcCtD
Almotriptan—Fatigue—Prednisone—chronic obstructive pulmonary disease	5.29e-05	0.00058	CcSEcCtD
Almotriptan—Headache—Prednisolone—chronic obstructive pulmonary disease	5.29e-05	0.00058	CcSEcCtD
Almotriptan—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	5.06e-05	0.000555	CcSEcCtD
Almotriptan—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	5.02e-05	0.000551	CcSEcCtD
Almotriptan—Nausea—Prednisolone—chronic obstructive pulmonary disease	5.02e-05	0.00055	CcSEcCtD
Almotriptan—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	4.85e-05	0.000532	CcSEcCtD
Almotriptan—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	4.85e-05	0.000532	CcSEcCtD
Almotriptan—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	4.52e-05	0.000496	CcSEcCtD
Almotriptan—Asthenia—Prednisone—chronic obstructive pulmonary disease	4.4e-05	0.000483	CcSEcCtD
Almotriptan—Pruritus—Prednisone—chronic obstructive pulmonary disease	4.34e-05	0.000476	CcSEcCtD
Almotriptan—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	4.2e-05	0.000461	CcSEcCtD
Almotriptan—Dizziness—Prednisone—chronic obstructive pulmonary disease	4.06e-05	0.000445	CcSEcCtD
Almotriptan—Vomiting—Prednisone—chronic obstructive pulmonary disease	3.9e-05	0.000428	CcSEcCtD
Almotriptan—Rash—Prednisone—chronic obstructive pulmonary disease	3.87e-05	0.000425	CcSEcCtD
Almotriptan—Dermatitis—Prednisone—chronic obstructive pulmonary disease	3.87e-05	0.000424	CcSEcCtD
Almotriptan—Headache—Prednisone—chronic obstructive pulmonary disease	3.84e-05	0.000422	CcSEcCtD
Almotriptan—CYP2C19—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	3.81e-05	0.00097	CbGpPWpGaD
Almotriptan—HTR1D—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	3.81e-05	0.000969	CbGpPWpGaD
Almotriptan—CYP2E1—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	3.79e-05	0.000964	CbGpPWpGaD
Almotriptan—HTR1B—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	3.78e-05	0.000963	CbGpPWpGaD
Almotriptan—HTR1B—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	3.73e-05	0.000949	CbGpPWpGaD
Almotriptan—MAOA—SIDS Susceptibility Pathways—CXCL8—chronic obstructive pulmonary disease	3.7e-05	0.000942	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	3.66e-05	0.000932	CbGpPWpGaD
Almotriptan—Nausea—Prednisone—chronic obstructive pulmonary disease	3.64e-05	0.0004	CcSEcCtD
Almotriptan—CYP2E1—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	3.64e-05	0.000926	CbGpPWpGaD
Almotriptan—CYP1A2—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	3.62e-05	0.000922	CbGpPWpGaD
Almotriptan—CYP2C8—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	3.61e-05	0.000919	CbGpPWpGaD
Almotriptan—CYP2E1—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	3.59e-05	0.000914	CbGpPWpGaD
Almotriptan—CYP1A2—Biological oxidations—GCLC—chronic obstructive pulmonary disease	3.58e-05	0.000912	CbGpPWpGaD
Almotriptan—CYP2C8—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	3.56e-05	0.000906	CbGpPWpGaD
Almotriptan—CYP2D6—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	3.55e-05	0.000905	CbGpPWpGaD
Almotriptan—MAOA—SIDS Susceptibility Pathways—IL1B—chronic obstructive pulmonary disease	3.55e-05	0.000903	CbGpPWpGaD
Almotriptan—FMO3—Metabolism—GSTT1—chronic obstructive pulmonary disease	3.51e-05	0.000895	CbGpPWpGaD
Almotriptan—CYP2D6—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	3.51e-05	0.000892	CbGpPWpGaD
Almotriptan—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—chronic obstructive pulmonary disease	3.48e-05	0.000885	CbGpPWpGaD
Almotriptan—FMO3—Metabolism—GCLC—chronic obstructive pulmonary disease	3.47e-05	0.000884	CbGpPWpGaD
Almotriptan—HTR1D—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	3.43e-05	0.000873	CbGpPWpGaD
Almotriptan—HTR1D—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	3.4e-05	0.000866	CbGpPWpGaD
Almotriptan—HTR1B—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	3.36e-05	0.000855	CbGpPWpGaD
Almotriptan—HTR1B—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	3.33e-05	0.000848	CbGpPWpGaD
Almotriptan—CYP2C8—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	3.32e-05	0.000845	CbGpPWpGaD
Almotriptan—CYP2C8—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	3.27e-05	0.000833	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	3.27e-05	0.000832	CbGpPWpGaD
Almotriptan—CYP2C19—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	3.22e-05	0.00082	CbGpPWpGaD
Almotriptan—CYP2C19—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	3.18e-05	0.000809	CbGpPWpGaD
Almotriptan—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	3.18e-05	0.000809	CbGpPWpGaD
Almotriptan—FMO3—Metabolism—CTGF—chronic obstructive pulmonary disease	3.17e-05	0.000807	CbGpPWpGaD
Almotriptan—MAOA—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	3.16e-05	0.000805	CbGpPWpGaD
Almotriptan—CYP2C8—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	3.15e-05	0.000801	CbGpPWpGaD
Almotriptan—HTR1D—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	3.11e-05	0.000793	CbGpPWpGaD
Almotriptan—CYP2C8—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	3.1e-05	0.00079	CbGpPWpGaD
Almotriptan—MAOA—Metabolism—GC—chronic obstructive pulmonary disease	3.07e-05	0.000783	CbGpPWpGaD
Almotriptan—HTR1B—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	3.05e-05	0.000776	CbGpPWpGaD
Almotriptan—HTR1D—G alpha (i) signalling events—CXCL8—chronic obstructive pulmonary disease	3.04e-05	0.000773	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	3.01e-05	0.000767	CbGpPWpGaD
Almotriptan—MAOA—SIDS Susceptibility Pathways—VEGFA—chronic obstructive pulmonary disease	3e-05	0.000765	CbGpPWpGaD
Almotriptan—HTR1D—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	2.98e-05	0.000758	CbGpPWpGaD
Almotriptan—HTR1B—G alpha (i) signalling events—CXCL8—chronic obstructive pulmonary disease	2.97e-05	0.000757	CbGpPWpGaD
Almotriptan—CYP2D6—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	2.96e-05	0.000755	CbGpPWpGaD
Almotriptan—CYP2C19—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	2.96e-05	0.000754	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	2.95e-05	0.000751	CbGpPWpGaD
Almotriptan—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—chronic obstructive pulmonary disease	2.94e-05	0.000749	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—APIP—chronic obstructive pulmonary disease	2.93e-05	0.000745	CbGpPWpGaD
Almotriptan—CYP2D6—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	2.92e-05	0.000744	CbGpPWpGaD
Almotriptan—FMO3—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.92e-05	0.000744	CbGpPWpGaD
Almotriptan—CYP2C19—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	2.92e-05	0.000744	CbGpPWpGaD
Almotriptan—HTR1B—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	2.91e-05	0.000742	CbGpPWpGaD
Almotriptan—MAOA—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.86e-05	0.000728	CbGpPWpGaD
Almotriptan—CYP2C19—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	2.81e-05	0.000715	CbGpPWpGaD
Almotriptan—CYP3A4—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	2.8e-05	0.000712	CbGpPWpGaD
Almotriptan—CYP2C19—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	2.77e-05	0.000705	CbGpPWpGaD
Almotriptan—CYP3A4—Biological oxidations—GCLC—chronic obstructive pulmonary disease	2.76e-05	0.000704	CbGpPWpGaD
Almotriptan—CYP2D6—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	2.72e-05	0.000693	CbGpPWpGaD
Almotriptan—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—chronic obstructive pulmonary disease	2.7e-05	0.000688	CbGpPWpGaD
Almotriptan—CYP2D6—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	2.69e-05	0.000684	CbGpPWpGaD
Almotriptan—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—chronic obstructive pulmonary disease	2.65e-05	0.000674	CbGpPWpGaD
Almotriptan—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—chronic obstructive pulmonary disease	2.65e-05	0.000674	CbGpPWpGaD
Almotriptan—CYP2D6—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	2.58e-05	0.000657	CbGpPWpGaD
Almotriptan—MAOA—SIDS Susceptibility Pathways—TNF—chronic obstructive pulmonary disease	2.57e-05	0.000655	CbGpPWpGaD
Almotriptan—CYP2D6—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	2.55e-05	0.000648	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	2.55e-05	0.000648	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—APIP—chronic obstructive pulmonary disease	2.53e-05	0.000644	CbGpPWpGaD
Almotriptan—CYP1A2—Aryl Hydrocarbon Receptor—TNF—chronic obstructive pulmonary disease	2.52e-05	0.000642	CbGpPWpGaD
Almotriptan—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—chronic obstructive pulmonary disease	2.52e-05	0.000642	CbGpPWpGaD
Almotriptan—CYP1A2—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	2.51e-05	0.000639	CbGpPWpGaD
Almotriptan—CYP1A2—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	2.48e-05	0.00063	CbGpPWpGaD
Almotriptan—FMO3—Metabolism—GSTP1—chronic obstructive pulmonary disease	2.44e-05	0.00062	CbGpPWpGaD
Almotriptan—HTR1D—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	2.41e-05	0.000615	CbGpPWpGaD
Almotriptan—FMO3—Metabolism—HMOX1—chronic obstructive pulmonary disease	2.4e-05	0.000612	CbGpPWpGaD
Almotriptan—HTR1B—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	2.36e-05	0.000602	CbGpPWpGaD
Almotriptan—CYP3A4—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	2.32e-05	0.000591	CbGpPWpGaD
Almotriptan—CYP1A2—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	2.31e-05	0.000587	CbGpPWpGaD
Almotriptan—CYP3A4—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	2.29e-05	0.000583	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	2.28e-05	0.000581	CbGpPWpGaD
Almotriptan—CYP1A2—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	2.28e-05	0.000579	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—APIP—chronic obstructive pulmonary disease	2.26e-05	0.000575	CbGpPWpGaD
Almotriptan—FMO3—Metabolism—GSTM1—chronic obstructive pulmonary disease	2.24e-05	0.00057	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	2.24e-05	0.000569	CbGpPWpGaD
Almotriptan—CYP1A2—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	2.19e-05	0.000557	CbGpPWpGaD
Almotriptan—CYP1A2—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	2.16e-05	0.000549	CbGpPWpGaD
Almotriptan—HTR1D—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	2.15e-05	0.000548	CbGpPWpGaD
Almotriptan—FMO3—Metabolism—CYP1A1—chronic obstructive pulmonary disease	2.12e-05	0.00054	CbGpPWpGaD
Almotriptan—HTR1B—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	2.11e-05	0.000536	CbGpPWpGaD
Almotriptan—MAOA—SIDS Susceptibility Pathways—IL6—chronic obstructive pulmonary disease	2.08e-05	0.000529	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—APIP—chronic obstructive pulmonary disease	2.08e-05	0.000529	CbGpPWpGaD
Almotriptan—HTR1D—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	1.95e-05	0.000497	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.94e-05	0.000494	CbGpPWpGaD
Almotriptan—CYP3A4—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	1.94e-05	0.000493	CbGpPWpGaD
Almotriptan—HTR1D—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	1.92e-05	0.000489	CbGpPWpGaD
Almotriptan—HTR1B—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	1.91e-05	0.000487	CbGpPWpGaD
Almotriptan—CYP3A4—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	1.91e-05	0.000487	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—GC—chronic obstructive pulmonary disease	1.89e-05	0.00048	CbGpPWpGaD
Almotriptan—HTR1B—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	1.88e-05	0.000479	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	1.84e-05	0.000468	CbGpPWpGaD
Almotriptan—HTR1D—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	1.84e-05	0.000468	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	1.8e-05	0.000459	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	1.8e-05	0.000459	CbGpPWpGaD
Almotriptan—HTR1B—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	1.8e-05	0.000458	CbGpPWpGaD
Almotriptan—CYP3A4—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	1.78e-05	0.000453	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—APIP—chronic obstructive pulmonary disease	1.76e-05	0.000448	CbGpPWpGaD
Almotriptan—CYP3A4—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	1.76e-05	0.000447	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.75e-05	0.000446	CbGpPWpGaD
Almotriptan—HTR1D—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	1.75e-05	0.000444	CbGpPWpGaD
Almotriptan—HTR1B—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	1.71e-05	0.000435	CbGpPWpGaD
Almotriptan—CYP3A4—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	1.69e-05	0.00043	CbGpPWpGaD
Almotriptan—HTR1D—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	1.68e-05	0.000428	CbGpPWpGaD
Almotriptan—MAOA—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.68e-05	0.000428	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.68e-05	0.000427	CbGpPWpGaD
Almotriptan—CYP3A4—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	1.67e-05	0.000424	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	1.66e-05	0.000423	CbGpPWpGaD
Almotriptan—MAOA—Metabolism—GCLC—chronic obstructive pulmonary disease	1.66e-05	0.000423	CbGpPWpGaD
Almotriptan—HTR1B—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	1.65e-05	0.000419	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—GC—chronic obstructive pulmonary disease	1.63e-05	0.000415	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	1.61e-05	0.00041	CbGpPWpGaD
Almotriptan—HTR1D—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	1.53e-05	0.000389	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.52e-05	0.000386	CbGpPWpGaD
Almotriptan—MAOA—Metabolism—CTGF—chronic obstructive pulmonary disease	1.52e-05	0.000386	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.5e-05	0.000381	CbGpPWpGaD
Almotriptan—HTR1B—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	1.5e-05	0.000381	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	1.48e-05	0.000378	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—GC—chronic obstructive pulmonary disease	1.46e-05	0.00037	CbGpPWpGaD
Almotriptan—FMO3—Metabolism—ALB—chronic obstructive pulmonary disease	1.44e-05	0.000367	CbGpPWpGaD
Almotriptan—MAOA—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.4e-05	0.000355	CbGpPWpGaD
Almotriptan—FMO3—Metabolism—NOS3—chronic obstructive pulmonary disease	1.38e-05	0.000351	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.38e-05	0.00035	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—APIP—chronic obstructive pulmonary disease	1.36e-05	0.000346	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.35e-05	0.000344	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	1.35e-05	0.000342	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—GC—chronic obstructive pulmonary disease	1.34e-05	0.000341	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	1.32e-05	0.000335	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	1.25e-05	0.000319	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—KL—chronic obstructive pulmonary disease	1.25e-05	0.000318	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.24e-05	0.000317	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—KL—chronic obstructive pulmonary disease	1.22e-05	0.000312	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	1.21e-05	0.000307	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.17e-05	0.000297	CbGpPWpGaD
Almotriptan—MAOA—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.16e-05	0.000296	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	1.15e-05	0.000294	CbGpPWpGaD
Almotriptan—MAOA—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.15e-05	0.000292	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—GC—chronic obstructive pulmonary disease	1.13e-05	0.000289	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	1.13e-05	0.000288	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	1.08e-05	0.000274	CbGpPWpGaD
Almotriptan—MAOA—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.07e-05	0.000272	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.05e-05	0.000268	CbGpPWpGaD
Almotriptan—HTR1D—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	1.04e-05	0.000265	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	1.03e-05	0.000263	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.03e-05	0.000262	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—GCLC—chronic obstructive pulmonary disease	1.02e-05	0.000259	CbGpPWpGaD
Almotriptan—HTR1B—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	1.02e-05	0.000259	CbGpPWpGaD
Almotriptan—MAOA—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.01e-05	0.000258	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	1.01e-05	0.000257	CbGpPWpGaD
Almotriptan—HTR1D—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	9.44e-06	0.00024	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	9.38e-06	0.000239	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—CTGF—chronic obstructive pulmonary disease	9.3e-06	0.000237	CbGpPWpGaD
Almotriptan—HTR1B—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	9.24e-06	0.000235	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	9.18e-06	0.000234	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	9.02e-06	0.00023	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	9e-06	0.000229	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—GSTT1—chronic obstructive pulmonary disease	8.91e-06	0.000227	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	8.84e-06	0.000225	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—GCLC—chronic obstructive pulmonary disease	8.81e-06	0.000224	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—GC—chronic obstructive pulmonary disease	8.75e-06	0.000223	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	8.56e-06	0.000218	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	8.4e-06	0.000214	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—LEP—chronic obstructive pulmonary disease	8.39e-06	0.000214	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—LEP—chronic obstructive pulmonary disease	8.21e-06	0.000209	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	8.21e-06	0.000209	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	8.14e-06	0.000207	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—CTGF—chronic obstructive pulmonary disease	8.04e-06	0.000205	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—GSTT1—chronic obstructive pulmonary disease	7.95e-06	0.000202	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—GCLC—chronic obstructive pulmonary disease	7.86e-06	0.0002	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—CYP1A2—chronic obstructive pulmonary disease	7.4e-06	0.000188	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	7.33e-06	0.000187	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—GSTT1—chronic obstructive pulmonary disease	7.31e-06	0.000186	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—GCLC—chronic obstructive pulmonary disease	7.23e-06	0.000184	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—CTGF—chronic obstructive pulmonary disease	7.17e-06	0.000183	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—GSTP1—chronic obstructive pulmonary disease	7.14e-06	0.000182	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—HMOX1—chronic obstructive pulmonary disease	7.05e-06	0.000179	CbGpPWpGaD
Almotriptan—HTR1D—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	6.9e-06	0.000176	CbGpPWpGaD
Almotriptan—MAOA—Metabolism—ALB—chronic obstructive pulmonary disease	6.89e-06	0.000176	CbGpPWpGaD
Almotriptan—HTR1B—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	6.75e-06	0.000172	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—CYP1A2—chronic obstructive pulmonary disease	6.61e-06	0.000168	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—CTGF—chronic obstructive pulmonary disease	6.6e-06	0.000168	CbGpPWpGaD
Almotriptan—MAOA—Metabolism—NOS3—chronic obstructive pulmonary disease	6.6e-06	0.000168	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	6.58e-06	0.000168	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—GSTM1—chronic obstructive pulmonary disease	6.56e-06	0.000167	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	6.45e-06	0.000164	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	6.28e-06	0.00016	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	6.22e-06	0.000158	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—GSTT1—chronic obstructive pulmonary disease	6.2e-06	0.000158	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—GSTP1—chronic obstructive pulmonary disease	6.17e-06	0.000157	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	6.15e-06	0.000157	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—GCLC—chronic obstructive pulmonary disease	6.12e-06	0.000156	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—HMOX1—chronic obstructive pulmonary disease	6.09e-06	0.000155	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—CYP1A2—chronic obstructive pulmonary disease	6.08e-06	0.000155	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	5.71e-06	0.000145	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—GSTM1—chronic obstructive pulmonary disease	5.67e-06	0.000144	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—CTGF—chronic obstructive pulmonary disease	5.59e-06	0.000142	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	5.57e-06	0.000142	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—GSTP1—chronic obstructive pulmonary disease	5.51e-06	0.00014	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	5.46e-06	0.000139	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—HMOX1—chronic obstructive pulmonary disease	5.44e-06	0.000138	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—CYP1A1—chronic obstructive pulmonary disease	5.38e-06	0.000137	CbGpPWpGaD
Almotriptan—HTR1D—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	5.3e-06	0.000135	CbGpPWpGaD
Almotriptan—HTR1B—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	5.19e-06	0.000132	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—GSTP1—chronic obstructive pulmonary disease	5.07e-06	0.000129	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—GSTM1—chronic obstructive pulmonary disease	5.06e-06	0.000129	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	5.04e-06	0.000128	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—HMOX1—chronic obstructive pulmonary disease	5e-06	0.000127	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	4.94e-06	0.000126	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—CYP1A1—chronic obstructive pulmonary disease	4.8e-06	0.000122	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	4.78e-06	0.000122	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—GCLC—chronic obstructive pulmonary disease	4.73e-06	0.00012	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—GSTM1—chronic obstructive pulmonary disease	4.66e-06	0.000119	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	4.53e-06	0.000115	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	4.43e-06	0.000113	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—CYP1A1—chronic obstructive pulmonary disease	4.42e-06	0.000112	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—CTGF—chronic obstructive pulmonary disease	4.31e-06	0.00011	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—GSTP1—chronic obstructive pulmonary disease	4.29e-06	0.000109	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—HMOX1—chronic obstructive pulmonary disease	4.24e-06	0.000108	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—ALB—chronic obstructive pulmonary disease	4.23e-06	0.000108	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	4.16e-06	0.000106	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	4.07e-06	0.000104	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	4.07e-06	0.000104	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—NOS3—chronic obstructive pulmonary disease	4.05e-06	0.000103	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	3.99e-06	0.000102	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	3.97e-06	0.000101	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—GSTM1—chronic obstructive pulmonary disease	3.95e-06	0.0001	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	3.74e-06	9.52e-05	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—ALB—chronic obstructive pulmonary disease	3.66e-06	9.31e-05	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—NOS3—chronic obstructive pulmonary disease	3.5e-06	8.9e-05	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—TP53—chronic obstructive pulmonary disease	3.42e-06	8.71e-05	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—TP53—chronic obstructive pulmonary disease	3.35e-06	8.53e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	3.31e-06	8.44e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	3.27e-06	8.32e-05	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—ALB—chronic obstructive pulmonary disease	3.26e-06	8.31e-05	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—IL6—chronic obstructive pulmonary disease	3.13e-06	7.97e-05	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—NOS3—chronic obstructive pulmonary disease	3.12e-06	7.95e-05	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—IL6—chronic obstructive pulmonary disease	3.07e-06	7.81e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	3.05e-06	7.75e-05	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—ALB—chronic obstructive pulmonary disease	3e-06	7.64e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	2.89e-06	7.35e-05	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—NOS3—chronic obstructive pulmonary disease	2.87e-06	7.31e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—ALB—chronic obstructive pulmonary disease	2.54e-06	6.47e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—NOS3—chronic obstructive pulmonary disease	2.43e-06	6.19e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—ALB—chronic obstructive pulmonary disease	1.96e-06	5e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—NOS3—chronic obstructive pulmonary disease	1.88e-06	4.78e-05	CbGpPWpGaD
